3d
MedPage Today on MSNSotatercept Helps the Sickest Patients With Pulmonary Arterial HypertensionCHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...
The addition of the aldosterone synthase inhibitor helped lower blood pressure in patients with resistant hypertension.
Early introduction of atorvastatin in patients with hypertension demonstrates sustained cardiovascular benefits, a 20-year ...
Blood pressure patterns observed in the first half of pregnancy, even among women without hypertensive disorders of pregnancy ...
A new study by investigators at Mass General Brigham shows that clues about hypertension may be buried in electronic health ...
Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...
Dexfenfluramine, aka Redux (also called “fen-phen” in combination with phentermine), was sold in the 1990s until it was ...
Blood pressure patterns observed in the first half of pregnancy, even among women without hypertensive disorders of pregnancy ...
UB research finds a new way to identify postpartum women who face an elevated risk for hypertension but are overlooked by ...
Pregnant individuals with consistently elevated systolic blood pressure (SBP), yet within the subclinical range, face a higher 5-year risk for hypertension.
Results from the Phase III ZENITH trial show that Winrevair lowered the risk of all-cause death, lung transplantation, and ...
NIH-supported study reveals new risk group for future high blood pressure and heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results